Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank82
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P82
Within normal range
vs 2Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.21% |
| Q3 2025 | -13.45% |
| Q2 2025 | 5.79% |
| Q1 2025 | -14.34% |
| Q4 2024 | 0.80% |
| Q3 2024 | -35.27% |
| Q2 2024 | 77.18% |
| Q1 2024 | -239.57% |
| Q4 2023 | 5.73% |
| Q3 2023 | 5.44% |
| Q2 2023 | 10.49% |
| Q1 2023 | -22.79% |
| Q4 2022 | -3.99% |
| Q3 2022 | 9.20% |
| Q2 2022 | 14.71% |
| Q1 2022 | -23.09% |
| Q4 2021 | -22.10% |
| Q3 2021 | 0.80% |
| Q2 2021 | -180.89% |
| Q1 2021 | 225.37% |
| Q4 2020 | -3.19% |
| Q3 2020 | -8.68% |
| Q2 2020 | 8.92% |
| Q1 2020 | -3.67% |
| Q4 2019 | 8.46% |
| Q3 2019 | 15.87% |
| Q2 2019 | -47.70% |
| Q1 2019 | -13.59% |
| Q4 2018 | -44.22% |
| Q3 2018 | -22.72% |
| Q2 2018 | 12.44% |
| Q1 2018 | -56.29% |
| Q4 2017 | -5.14% |
| Q3 2017 | -47.25% |
| Q2 2017 | -6.95% |
| Q1 2017 | 23.98% |
| Q4 2016 | -30.90% |
| Q3 2016 | 2.10% |
| Q2 2016 | -5.58% |
| Q1 2016 | 8.43% |